Overview

Lansoprazole to Treat Children With Asthma

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
Many individuals with asthma also experience gastroesophageal reflux disease (GERD), a condition in which excess stomach acid flows backwards into the esophagus. This study will evaluate the effectiveness of lansoprazole, a medication commonly used to treat GERD in improving asthma control and reducing symptoms in children with poorly controlled asthma.
Phase:
Phase 4
Details
Lead Sponsor:
Emory University
Johns Hopkins University
Collaborators:
American Lung Association
American Lung Association Asthma Clinical Research Centers
Baylor College of Medicine
Duke University
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI)
Nemours Children's Clinic
New York Medical College
Ohio State University
University of Manitoba
University of Vermont
Washington University School of Medicine
Treatments:
Dexlansoprazole
Lansoprazole